secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lunai Bioworks Inc. (LNAI)
CIK:        0001527728
Form:       8-K
Filed at:   2023-10-10T23:59:59+00:00
Accession:  0001731122-23-001825
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Renovaro Biosciences appoints Leni Boeren and Ruud Hendriks as independent directors
--------------------------------------------------------------------------------

- Board increased to 10 members; Boeren and Hendriks appointed effective October 4, 2023.
- Boeren brings 40 years in finance, including CEO of Robeco Groep and NIBC Bank board.
- Hendriks has 35+ years in asset management, including co-head of EMEA sales at Goldman Sachs.
- New directors will serve until 2024 annual meeting; compensation per standard independent director agreement.
- Appointments come as Renovaro pursues definitive combination with GEDi Cube Intl Ltd., announced Sept 29.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527728/000173112223001825/0001731122-23-001825-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527728/000173112223001825/e5109_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-23-001825

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer